CCL2 and breast carcinoma: Further corroborating our findings, we found that mRNAs for CXCL16 as well as for IL8, CSF2, MMP9, EDN1 and CCL2 all were expressed at significantly higher levels in basal-like breast cancers as compared with luminal A tumours (Fig. 7a).